The letter, sent to FDA Commissioner Robert Califf, requested documents and a briefing on how the agency is monitoring and working to end drug shortages, according to the publication.
“The FDA is failing to ensure vitally important pharmaceuticals remain on pharmacy shelves,” the lawmakers wrote, adding that the problem with shortages predates the COVID-19 pandemic.
In a statement shared with The Hill, the FDA indicated it had received the letter and will respond directly to the committee. It said it is working closely with manufacturers to mitigate the effects of shortages.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.